Blog - FreeMind Group

Everybody 12 /Case Studies 0 /Conferences 9 /FreeMind Elite 0 /FreeMind Elite 2024 0 /Job posting 0 /NDFS 2025 Presentations 0 /News 3 /Opinions 0 /Opportunities 1 /Presentations 0 /Uncategorized 0 /Webinars 0

Longevity Leaders World Congress — Longevity Leaders World Congress, April 26-27, 2022 (London)
March 22, 2022/by Ayal Ronen

Bio-Europe Spring — Bio-Europe Spring, March 28-31, 2022 (Online)
March 20, 2022/by Ayal Ronen

The Advanced Research Projects Agency for Health. What is it? What will it fund? — ARPA-H: What R&D will be funded by the “DARPA for Health”?
March 16, 2022/by Ayal Ronen

How will Congress' $1.5 Trillion Allocations Bill affect Biotech, Medtech, Health-tech, and biopharma — How will Congress’ $1.5-Trillion Allocations Bill Affect Life Science R&D?
March 14, 2022/by Ayal Ronen

Cell and Gene Meeting on the Med 2022, April 20-22 and 26-27, hybrid: barcelona and online — Cell & Gene Meeting on the Med, April 20–22 & 26-27, 2022 (Hybrid: Barcelona & Online)
March 3, 2022/by Ayal Ronen

Bio Europe Spring March 28-31, 2022 delivered digitally — Bio-Europe Spring, March 28–31, 2022 (online)
March 2, 2022/by Ayal Ronen

Sachs Associates Neuroscience Innovation Forum March 2022 — Neuroscience Innovation Forum, March 2022
February 28, 2022/by Ayal Ronen

RESI Digital Conference March 2022 — RESI Digital, March 2022
February 28, 2022/by Ayal Ronen

RNA Leaders banner — RNA Leaders World Congress 2022
February 28, 2022/by Ayal Ronen

ELSF 2022 banner — The 15th Annual European Life Sciences CEO Forum
February 28, 2022/by Ayal Ronen

EHTF 2022 graphic — European Healthcare CEO Forum
February 24, 2022/by Ayal Ronen

Will there be new funding opportunities in the billions more Biden wants to spend on COVID — New R&D funding opportunities in Biden billions for COVID?
February 23, 2022/by Ayal Ronen

Reach out to us with your non-dilutive funding requirements

Contact us Who we are

Subscribe to our Newsletter